🕒 Created

CAR-T therapy has revolutionized blood cancer treatment, particularly in multiple myeloma, but questions remain regarding cancer progression.

CAR-T therapy has revolutionized the treatment of blood cancers, with significant success in multiple myeloma. While the therapy has become a standard for many patients, a primary concern remains for medical professionals and patients alike.

Show the rest of this summary

If a patient's cancer progresses after receiving CAR-T treatment, the subsequent treatment options are still being evaluated. Researchers are currently investigating what other therapies or procedures can be used effectively to follow up on CAR-T therapy when the cancer begins to return or advance.

Sources

Paywall and unreadable sources